Oxford BioMedica (OXBDF)
(Delayed Data from OTC)
$4.60 USD
-0.08 (-1.60%)
Updated Aug 23, 2024 11:37 AM ET
2-Buy of 5 2
C Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | NA |
---|---|
Current Quarter | NA |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.75 |
Earnings ESP
|
NA |
---|---|
Current Year | -0.34 |
Next Year | -0.28 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 161.04M | 201.42M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 161.04M | 201.42M |
Low Estimate | NA | NA | 161.04M | 201.42M |
Year ago Sales | NA | NA | 173.19M | 161.04M |
Year over Year Growth Est. | NA | NA | -7.02% | 25.07% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -0.34 | -0.28 |
# of Estimates | NA | NA | 2 | 1 |
Most Recent Consensus | NA | NA | -0.22 | NA |
High Estimate | NA | NA | -0.22 | -0.28 |
Low Estimate | NA | NA | -0.46 | -0.28 |
Year ago EPS | NA | NA | NA | -0.34 |
Year over Year Growth Est. | NA | NA | NA | 17.65% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | 0 |
Up Last 30 Days | NA | NA | 1 | 1 |
Up Last 60 Days | NA | NA | 1 | 1 |
Down Last 7 Days | NA | NA | 0 | 0 |
Down Last 30 Days | NA | NA | 0 | 0 |
Down Last 60 Days | NA | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -0.34 | -0.28 |
7 Days Ago | NA | NA | -0.34 | -0.28 |
30 Days Ago | NA | NA | -0.40 | -0.44 |
60 Days Ago | NA | NA | -0.40 | -0.44 |
90 Days Ago | NA | NA | -0.40 | -0.44 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -0.46 | -0.28 |
Zacks Consensus Estimate | NA | NA | -0.34 | -0.28 |
Earnings ESP | NA | NA | -35.29% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | NA | NA | NA | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more